• Je něco špatně v tomto záznamu ?

Vancomycin wound penetration in open-heart surgery patients receiving negative pressure wound therapy for deep sternal wound infection

M. Kolek, J. Ďuricová, H. Brozmanová, P. Šištík, J. Juřica, K. Kaňková, O. Motyka, I. Kacířová

. 2025 ; 57 (1) : 2444544. [pub] 20241223

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, pozorovací studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc25002813

INTRODUCTION: It is hypothesized that systemically administered antibiotics penetrate wound sites more effectively during negative pressure wound therapy (NPWT). However, there is a lack of clinical data from patients who receive NPWT for deep sternal wound infection (DSWI) after open-heart surgery. Here, we evaluated vancomycin penetration into exudate in this patient group. PATIENTS AND METHODS: For this prospective observational study, we enrolled 10 consecutive patients treated with NPWT for post-sternotomy DSWI. On the first sampling day, serum and exudate samples were synchronously collected at 0 (pre-dose), 0.5, 1, 2, 3 and 6 h after vancomycin administration. On the following three consecutive days, additional samples were collected, only before vancomycin administration. RESULTS: The ratio of average vancomycin concentration in wound exudate to in serum was higher for free (unbound) (1.51 ± 0.53) than for total (bound + unbound) (0.91 ± 0.29) concentration (p = 0.049). The percentage of free vancomycin was higher in wound exudate than serum (0.79 ± 0.19 vs. 0.46 ± 0.16; p = 0.04). Good vancomycin wound penetration was maintained on the following three days (vancomycin trough exudate-to-serum concentration ratio > 1). The total hospital stay was significantly longer in patients with DSWI (46 ± 11.6 days) versus without DSWI (14 ± 11.7 days) (p < 0.001). There was no in-hospital or 90-day mortality. Two patients experienced late DSWI recurrence. All-cause mortality was 4.8% during a median follow-up of 2.5 years. CONCLUSION: Vancomycin effectively penetrates wound exudate in patients receiving NPWT for DSWI after open-heart surgery.The protocol for this study was registered at ClinicalTrials.gov on July 16, 2024 (NCT06506032).

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25002813
003      
CZ-PrNML
005      
20250206103904.0
007      
ta
008      
250121s2025 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1080/07853890.2024.2444544 $2 doi
035    __
$a (PubMed)39711425
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Kolek, Martin $u Department of Cardiac Surgery, University Hospital Ostrava, Ostrava, Czech Republic $u Department of Clinic Subjects, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic $1 https://orcid.org/0000000204183006
245    10
$a Vancomycin wound penetration in open-heart surgery patients receiving negative pressure wound therapy for deep sternal wound infection / $c M. Kolek, J. Ďuricová, H. Brozmanová, P. Šištík, J. Juřica, K. Kaňková, O. Motyka, I. Kacířová
520    9_
$a INTRODUCTION: It is hypothesized that systemically administered antibiotics penetrate wound sites more effectively during negative pressure wound therapy (NPWT). However, there is a lack of clinical data from patients who receive NPWT for deep sternal wound infection (DSWI) after open-heart surgery. Here, we evaluated vancomycin penetration into exudate in this patient group. PATIENTS AND METHODS: For this prospective observational study, we enrolled 10 consecutive patients treated with NPWT for post-sternotomy DSWI. On the first sampling day, serum and exudate samples were synchronously collected at 0 (pre-dose), 0.5, 1, 2, 3 and 6 h after vancomycin administration. On the following three consecutive days, additional samples were collected, only before vancomycin administration. RESULTS: The ratio of average vancomycin concentration in wound exudate to in serum was higher for free (unbound) (1.51 ± 0.53) than for total (bound + unbound) (0.91 ± 0.29) concentration (p = 0.049). The percentage of free vancomycin was higher in wound exudate than serum (0.79 ± 0.19 vs. 0.46 ± 0.16; p = 0.04). Good vancomycin wound penetration was maintained on the following three days (vancomycin trough exudate-to-serum concentration ratio > 1). The total hospital stay was significantly longer in patients with DSWI (46 ± 11.6 days) versus without DSWI (14 ± 11.7 days) (p < 0.001). There was no in-hospital or 90-day mortality. Two patients experienced late DSWI recurrence. All-cause mortality was 4.8% during a median follow-up of 2.5 years. CONCLUSION: Vancomycin effectively penetrates wound exudate in patients receiving NPWT for DSWI after open-heart surgery.The protocol for this study was registered at ClinicalTrials.gov on July 16, 2024 (NCT06506032).
650    _2
$a lidé $7 D006801
650    12
$a terapie ran pomocí řízeného podtlaku $x metody $7 D054843
650    _2
$a mužské pohlaví $7 D008297
650    12
$a vankomycin $x aplikace a dávkování $x farmakokinetika $7 D014640
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a senioři $7 D000368
650    12
$a infekce chirurgické rány $7 D013530
650    _2
$a prospektivní studie $7 D011446
650    12
$a antibakteriální látky $x farmakokinetika $x aplikace a dávkování $7 D000900
650    _2
$a lidé středního věku $7 D008875
650    12
$a kardiochirurgické výkony $x škodlivé účinky $7 D006348
650    12
$a sternotomie $x škodlivé účinky $7 D056346
650    _2
$a exsudáty a transsudáty $x metabolismus $x mikrobiologie $7 D005122
650    _2
$a sternum $x chirurgie $7 D013249
655    _2
$a časopisecké články $7 D016428
655    _2
$a pozorovací studie $7 D064888
700    1_
$a Ďuricová, Jana $u Department of Clinical Pharmacology, Institute of Laboratory Medicine, University Hospital Ostrava, Ostrava, Czech Republic $u Department of Clinical Pharmacology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic $1 https://orcid.org/0000000241584896 $7 xx0094983
700    1_
$a Brozmanová, Hana $u Department of Clinical Pharmacology, Institute of Laboratory Medicine, University Hospital Ostrava, Ostrava, Czech Republic $u Department of Clinical Pharmacology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic $1 https://orcid.org/0000000205863927
700    1_
$a Šištík, Pavel $u Department of Clinical Pharmacology, Institute of Laboratory Medicine, University Hospital Ostrava, Ostrava, Czech Republic $u Department of Clinical Pharmacology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic $1 https://orcid.org/0000000333479540 $7 xx0222729
700    1_
$a Juřica, Jan $u Department of Pharmacology, Faculty of Medicine, Masaryk University, Brno, Czech Republic $u Hospital Pharmacy, Masaryk Memorial Cancer Institute, Brno, Czech Republic $1 https://orcid.org/0000000202576711 $7 xx0085543
700    1_
$a Kaňková, Klára $u Department of Cardiac Surgery, University Hospital Ostrava, Ostrava, Czech Republic $1 https://orcid.org/0009000979121094
700    1_
$a Motyka, Oldřich $u Department of Environmental Engineering, Faculty of Mining and Geology, VŠB - Technical University of Ostrava, Ostrava, Czech Republic $1 https://orcid.org/0000000296440611 $7 xx0228211
700    1_
$a Kacířová, Ivana $u Department of Clinical Pharmacology, Institute of Laboratory Medicine, University Hospital Ostrava, Ostrava, Czech Republic $u Department of Clinical Pharmacology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic $1 https://orcid.org/000000016618754X $7 xx0081201
773    0_
$w MED00009195 $t Annals of medicine $x 1365-2060 $g Roč. 57, č. 1 (2025), s. 2444544
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39711425 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250121 $b ABA008
991    __
$a 20250206103900 $b ABA008
999    __
$a ok $b bmc $g 2262927 $s 1238820
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 57 $c 1 $d 2444544 $e 20241223 $i 1365-2060 $m Annals of medicine $n Ann Med $x MED00009195
LZP    __
$a Pubmed-20250121

Najít záznam

Citační ukazatele

Možnosti archivace